Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast Cancer
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if BMS-690514 + letrozole will be more effective
than lapatinib + letrozole in patients who have metastatic hormone receptor positive breast
cancer after developing progressive disease immediately following adjuvant antiendocrine
therapy